Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Urine Test Produces Antibiotic Susceptibility Results Directly

By LabMedica International staff writers
Posted on 10 Jul 2019
Antibiotic susceptibility testing, or AST, is a widely used method of evaluating antibiotic resistance and determining patient treatment plans in clinical settings. More...
There are a number of different methods of AST such as agar dilution, broth dilution and disc diffusion assays.

Empiric treatment is often started before laboratory microbiological reports are available when treatment should not be delayed due to the seriousness of the disease. The effectiveness of individual antibiotics varies with the location of the infection, the ability of the antibiotic to reach the site of infection, and the ability of the bacteria to resist or inactivate the antibiotic.

Microbiologists at the Groupe Hospitalier Paris-Saint-Joseph (Paris, France) collected urine samples were collected from 107 patients aged 52 to 80 years with urinary tract infections (UTIs) (ratio of females to males 2:1). The median C-reactive protein was 104 mg/L (range, 39-145). The urine specimens displayed a median leukocyturia of 380/mm3 (range, 192-1,497) and median bacteriuria of 106 colony forming units/mL (range, 105-107). Only gram-negative bacilli were evident on direct examination using microscopy.

A novel rapid method was performed by direct inoculation of urine on Mueller-Hinton Rapid-SIR (MHR-SIR) agar using a swab according to a standard protocol. The resulting inhibition zones were read from digital images after eight-hours of incubation and were interpreted using standard methods. Of 70 patients who were currently receiving antibiotic therapy, the results prompted a shift in therapy for 29 patients, with no modification for the remaining 41. The most commonly used antibiotics were third generation cephalosporins, followed by fluoroquinolones, beta-lactamase inhibitors, fosfomycin, and nitrofurantoin. The rapid results lead to treatment escalation in 7% of the patients and de-escalation in 30%. The average time to obtain results was 7.2 ± 1.6 hours, representing a time saving of 42.6 hours compared with the standard technique.

The team noted that the method was affordable, with an average cost of USD 6 per sample for 16 antibiotics chosen by a microbiologist. Benoît Pilmis, MD, an infectious disease specialist and a co-author of the study, said, “The diagnosis of urinary tract infection generally requires a 48-hour microbiological delay to obtain the antibiotic susceptibility test. In the context of multidrug resistance, reducing the time to obtain antibiotic susceptibility test results is an essential issue to avoid treatment failure. The rapidity of the results impact the therapeutic management of patients as it enables not only the prescription of the most relevant antibiotic, but also the reduction of the spectrum of antibiotic therapy.” The study was presented at Annual meeting of the American Society of Microbiology, held June 7-11, 2019, in Atlanta, GA, USA.

Related Links:
Groupe Hospitalier Paris-Saint-Joseph


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
POC Immunoassay Analyzer
Procise DX
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
image Credit: iStock

Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

Outcomes after resection for lung squamous cell carcinoma (SqCC) vary substantially, and the uneven benefit of adjuvant chemotherapy complicates postsurgical treatment decisions. Pathologic markers that... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.